Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low or Intermediate Risk Prostate Cancer”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableEnded earlyNCT02454517
What this trial is testing

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7
Fred Hutchinson Cancer Center 117
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Not applicableStudy completedNCT02342626
What this trial is testing

Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer

Who this might be right for
Adenocarcinoma of Prostate
University of Rochester 140
Early research (Phase 1)Ended earlyNCT02875223
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 75
Large-scale testing (Phase 3)Study completedNCT00002723
What this trial is testing

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 390
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableActive Not RecruitingNCT02339701
What this trial is testing

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 68
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Not applicableLooking for participantsNCT07130682
What this trial is testing

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Who this might be right for
Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT04984343
What this trial is testing

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 33
Not applicableEnded earlyNCT01717677
What this trial is testing

Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk

Who this might be right for
Prostate Cancer
Association of Urologic Oncology (AUO) 457
Not applicableActive Not RecruitingNCT00890006
What this trial is testing

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Who this might be right for
Low or Intermediate Risk Prostate Cancer
University Health Network, Toronto 99
Not applicableActive Not RecruitingNCT01352429
What this trial is testing

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 303
Not applicableStudy completedNCT04307056
What this trial is testing

Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY

Who this might be right for
Prostate CancerUltrasound Therapy
Association Francaise d'Urologie 3,862
Not applicableActive Not RecruitingNCT01617161
What this trial is testing

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 454
Not applicableEnded earlyNCT05826470
What this trial is testing

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Who this might be right for
Prostate CancerLow-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
Genesis Research LLC 4
Not applicableWithdrawnNCT04399824
What this trial is testing

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT02104362
What this trial is testing

Single Fraction Early Prostate Irradiation (SiFEPI)

Who this might be right for
Prostate Cancer
Centre Antoine Lacassagne 35
Not applicableLooking for participantsNCT06117059
What this trial is testing

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

Who this might be right for
Localized Prostate CancerLow Risk Prostate CancerIntermediate Risk Prostate Cancer
NHS Lothian 100
Not applicableUnknownNCT04100811
What this trial is testing

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Who this might be right for
Prostate Cancer
miR Scientific LLC 2,019
Next Page